Beikang Medical

BiotechnologySeries AHangzhou, China

Latest round

Series A

Last raised

Nov 2025

Total raised

Undisclosed

Investors

2

About Beikang Medical

Founded in 2021 and based in Jiaxing, China, Beikang Medical is a biotechnology company engaged in stem cell culture, differentiation, and industrialization. It is a pioneer in China's in vitro preparation and encapsulation technology of stem cell-derived pancreatic islet cells, possessing fully independent core technologies., Ltd. The company provides China's in vitro preparation and encapsulation technology of stem cell-derived pancreatic islet cells, dedicated to using stem cell technology to cultivate healthy human tissues or organs to replace diseased tissues. The company generates revenue by providing China's in vitro preparation and encapsulation technology of stem cell-derived pancreatic islet cells.

Who invested in Beikang Medical

2 investors across 1 round

See all investors in Beikang Medical

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 10, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about Beikang Medical

Who invested in Beikang Medical?

Beikang Medical has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Beikang Medical raised?

Beikang Medical has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Beikang Medical last raise money?

Beikang Medical's most recent round on record is a Series A, in Nov 2025.

What does Beikang Medical do?

Founded in 2021 and based in Jiaxing, China, Beikang Medical is a biotechnology company engaged in stem cell culture, differentiation, and industrialization.

Where is Beikang Medical headquartered?

Beikang Medical is headquartered in Hangzhou, China.

Which VCs invest in companies like Beikang Medical?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beikang Medical's stage. Their profiles are linked below.

Raising like Beikang Medical? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.